Reduced brain-derived neurotrophic factor (BDNF) levels are considered to be a pathogenic event in early AD and even in the earliest, prodromal stages of dementia (e.g., MCI) [42,43]. The gene discussed is BDNF; the disease is Alzheimer disease.